Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


European Pharmaceutical Pricing & Reinbursement

29 Oct 2012 - 30 Oct 2012 - London, UK



Bookmark and Share


SMi are proud to present their 18th annual market leading European Pharmaceutical Pricing and Reimbursement conference. This year’s event will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as market access strategies, recent developments in the healthcare landscape and challenges in VBP and AMNOG. As well as exclusive presentations on the latest P&R developments across Europe and further afield, the event will act as a unique forum for attendees to learn, make connections and explore new ideas.

Key benefits of attending:

Hear from experts in the field on Value Based Pricing: Principles and practice

Debate EU policy challenges in access to medicines in Europe with experts from Germany, Italy, UK, Switzerland and Belgium

Analyse market access in Russia, Turkey and Eastern Europe

Learn about the latest regulations within pricing and reimbursement from industry

Understand the facts and consequences of Germany’s AMNOG

Discover the value of collaboration in HTA and managed entry schemes

Consider an international view with perspectives from the Asia-Pac Region and North America

Network with and learn from senior industry representatives from companies such as Sanofi, GSK, Abbott & UCB 

Quote “Technology Network” and save £100

Register online here: http://www.smi-online.co.uk/goto/2012europricing26.asp



Further information
Scientific News
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Microalgae Make a Splash in the UK Cosmeceutical Market
Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market.
Mechanism of Tumor Suppressing Gene Uncovered
The most commonly mutated gene in cancer,p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
Useful Colon Cancer Biomarker Discovered
Biomarker is detectable with simple, inexpensive test.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Seeing Hope
Gene therapy/drug combo restores some vision in mice with optic nerve injury.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!